Neal Masia is an Adjunct Professor of Business and Economics at Columbia University and serves as a consultant and advisor to a variety of healthcare companies and healthcare-focused investment firms. Neal spent nearly 18 years rising through the ranks at Pfizer Inc, most recently as Chief Economist and Vice President of Patient and Health Impact. As a member of Pfizer’s Senior Leadership Council, Neal advised the Executive Leadership Team and Board of Directors on how global economic forces would shape the healthcare industry, and he worked closely with the CFO on all significant strategic transactions and business development opportunities. Neal built and managed major commercial enterprise platform functions including Global Pricing, Real World Data and Analytics, Patient-Centered Outcomes, and Market Access/HTA Methods and Capabilities. He also spent nearly 10 years in Finance, where he led Capital Strategy, International Treasury, investment allocations in Pfizer’s $16 billion pension plan, and Capital Markets. Earlier in his Pfizer career Neal held roles in public policy and corporate strategy. Before joining Pfizer, Neal worked as a consultant at the Advisory Board Company, as an economist with the U.S. Congressional Budget Office, in planning and marketing at a venture-backed insurance technology startup, and as a policy advisor to Senator Bill Bradley during his 2000 Presidential campaign. Neal earned a B.A. (High Honors) in Mathematical Economics from Colgate University and a Ph.D. in Economics (specializing in Public Finance and Game Theory) from the University of Rochester.